| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business &Strat Officer | Senior Vice President
1 company
Delong Mark Jeffrey is a Chief Business &Strat Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $4.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2022 | APLS Apellis Pharmaceuticals, Inc. | Senior Vice President | Sale+OE | 7,000 | $52.53 | $367,710.00 | -19.7% | -1.5% | +55.9% | |
| Jul 21, 2021 | APLS Apellis Pharmaceuticals, Inc. | Senior Vice President | Sale+OE | 1,000 | $65.00 | $65,000.00 | -9.5% | -50.1% | -20.9% | |
| Jul 15, 2021 | APLS Apellis Pharmaceuticals, Inc. | Senior Vice President | Sale+OE | 1,000 | $62.30 | $62,300.00 | -9.5% | -45.8% | -26.4% | |
| Jun 15, 2021 | APLS Apellis Pharmaceuticals, Inc. | Senior Vice President | Sale+OE | 4,000 | $64.96 | $259,830.00 | -29.7% | -46.9% | -32.1% | |
| May 18, 2021 | APLS Apellis Pharmaceuticals, Inc. | Senior Vice President | Sale+OE | 2,000 | $55.00 | $110,000.00 | -17.4% | +9.5% | -15.2% |